Trial intelligence / Profile preview

Dose-ranging pharmacodynamic study of topical Aldara (imiquimod) in healthy volunteers

2016-000331-41Phase 4Completed

Sponsor
Centre for Human Drug Research
Start
Mar 2016
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of imiquimod, sponsored by Centre for Human Drug Research. Started Mar 2016; status: completed.

02

Drugs

imiquimod

Beyond the preview

Go deeper on 2016-000331-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000331-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call